| |
| Biomarkers for Cardiovascular Risk with a Focus on BNP |
| Michael Clark, MD, FACC, DBIM and Mike Fulks, MD |
|
|
| |
|
Our panel will discuss biomarkers associated with cardiovascular
mortality including those related to plaque and vascular vulnerability
(more traditional risk factors/tests) but focus on left ventricular function
(NT-ProBNP). The BNP discussion will include recently published industry
mortality data as well as other supplementary literature. We will include
discussion on the use of cardiovascular biomarkers together to provide
a better overall measurement of cardiovascular risk.
|
| |
|
